Interleukin-15 as an Immune Adjuvant To Increase the Efficacy of Mycobacterium bovis Bacillus Calmette-Guérin Vaccination

Interleukin-15 (IL-15) transgenic mice which had been inoculated with Mycobacterium bovis bacillus Calmette-Guérin (BCG) 24 weeks previously showed resistance against airborne infection with Mycobacterium tuberculosis H37Rv accompanied by an increased CD8(+)-Tc1-cell response. IL-15 may be used as a...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Umemura, Masayuki, Nishimura, Hitoshi, Saito, Kimika, Yajima, Toshiki, Matsuzaki, Goro, Mizuno, Satoru, Sugawara, Isamu, Yoshikai, Yasunobu
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2003
Matèries:
Microbial Immunity and Vaccines
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC201060/
https://ncbi.nlm.nih.gov/pubmed/14500526
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/IAI.71.10.6045-6048.2003
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars